Literature DB >> 23611994

Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients.

Nicole Guyette1, Larezia Williams, My-Tho Tran, Tammy Than, John Bradley, Lucy Kehinde, Clara Edwards, Mark Beasley, Roderick Fullard.   

Abstract

PURPOSE: Low tear volume limits the use of nonstimulated (NS) microcapillary tear collection in aqueous-deficient (AD) patients. Adding a small amount of "washout" fluid to the eye prior to tear collection is a potentially viable alternative method for abundant proteins, but is relatively untested for low-abundance biomarkers. This study determined the feasibility of the washout (WO) method as an NS alternative for low-abundance biomarkers. NS and WO biomarker profiles were compared between AD patients and non-AD controls to determine if the two methods identify the same intergroup differences.
METHODS: Matching NS and WO tears were collected from 48 patients by micropipette, the WO sample after instillation of 10 μL saline. Tear cytokine levels were measured by 27-Plex Bio-Rad assay. Bland-Altman analyses for each biomarker determined the agreement between tear sample types. Patients were grouped as AD or non-AD based on Schirmer score to determine if NS profile between-group differences were preserved in WO tears.
RESULTS: Bland-Altman plots showed good biomarker level agreement between NS and WO tears for most cytokines. Five biomarkers, among those most often cited as differing in AD dry eye, differed significantly between non-AD and AD groups in both tear types. Additional biomarker differences were seen in NS tears only.
CONCLUSIONS: The WO tear collection method is a viable alternative to NS tears for many low-abundance biomarkers and is able to replicate major NS tear differences between dry eye groups. More subtle intergroup differences are lost in WO samples because of reduced statistical power.

Entities:  

Keywords:  aqueous deficient; non-stimulated tears; tear biomarkers; washout tears

Mesh:

Substances:

Year:  2013        PMID: 23611994      PMCID: PMC3668804          DOI: 10.1167/iovs.12-11431

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

1.  Variability of tear protein levels in normal young adults: diurnal (daytime) variation.

Authors:  V Ng; P Cho; F Wong; Y Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-04       Impact factor: 3.117

2.  A comparison of diagnostic tests for keratoconjunctivitis sicca: lactoplate, Schirmer, and tear osmolarity.

Authors:  J A Lucca; J N Nunez; R L Farris
Journal:  CLAO J       Date:  1990 Apr-Jun

3.  Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay.

Authors:  Martin W LaFrance; Lucy E Kehinde; Roderick J Fullard
Journal:  Curr Eye Res       Date:  2008-07       Impact factor: 2.424

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Tear protein composition and the effects of stimulus.

Authors:  R J Fullard; D Tucker
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

Review 6.  Cellular sources and immune functions of interleukin-9.

Authors:  Randolph J Noelle; Elizabeth C Nowak
Journal:  Nat Rev Immunol       Date:  2010-09-17       Impact factor: 53.106

7.  Roles of caspase 1 and extracellular signal-regulated kinase in inflammation-induced inhibition of lacrimal gland protein secretion.

Authors:  Driss Zoukhri; Sunghwan Ko; Paul C Stark; Claire L Kublin
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

8.  Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.

Authors:  Megan E Cavet; Karen L Harrington; Keith W Ward; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2010-09-02       Impact factor: 2.367

Review 9.  The biology of IL-12: coordinating innate and adaptive immune responses.

Authors:  Wendy T Watford; Masato Moriguchi; Akio Morinobu; John J O'Shea
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

Review 10.  Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007).

Authors: 
Journal:  Ocul Surf       Date:  2007-04       Impact factor: 5.033

View more
  4 in total

Review 1.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

2.  Tear fluid extracellular DNA: diagnostic and therapeutic implications in dry eye disease.

Authors:  Sapna Tibrewal; Joy Sarkar; Sarmad H Jassim; Sonal Gandhi; Snehal Sonawane; Shweta Chaudhary; Yong-Soo Byun; Yair Ivanir; Joelle Hallak; John H Horner; Martin Newcomb; Sandeep Jain
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-11       Impact factor: 4.799

3.  Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder.

Authors:  Tugba Ozturk; Alexander Kollhoff; Albert M Anderson; J Christina Howell; David W Loring; Drenna Waldrop-Valverde; Donald Franklin; Scott Letendre; William R Tyor; William T Hu
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

4.  Human tear analysis with miniaturized multiplex cytokine assay on "wall-less" 96-well plate.

Authors:  Xavier Le Guezennec; Joanne Quah; Louis Tong; Namyong Kim
Journal:  Mol Vis       Date:  2015-10-13       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.